However, the apoptosis rates of normal glial cells induced by gefitinib alone or combination treatment were dramatically less than those in the glioma cells, which may be resulted from the lower expression of EGFR in normal cells than glioma cells. This evidence concerns the gene EGFR and central nervous system cancer.